Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

Myocarditis

Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,325

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627

Preliminary evidence on long COVID in children

Buonsenso, D., Munblit, D., Rose, C. D., Sinatti, D., Ricchiuto, A., Carfì, A., & Valentini, P. (2021) · Acta Paediatrica · doi:10.1111/apa.15870 · Cited by 508

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Payne, A. B., Gilani, Z., Godfred‐Cato, S., Belay, E. D., Feldstein, L. R., Patel, M. M., Randolph, A. G., Newhams, M. M., Thomas, D., Magleby, R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16420 · Cited by 395

The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

Baggs, J. M., Gee, J. M., Lewis, E. M., Fowler, G. L., Benson, P. J., Lieu, T. A., Naleway, A. L., Klein, N. P., Baxter, R. P., Belongia, E. A., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722h · Cited by 349

The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood

Kytö, V., Sipilä, J., & Rautava, P. (2013) · Heart · doi:10.1136/heartjnl-2013-304449 · Cited by 124

Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007–2016

Vasudeva, R., Bhatt, P. J., Lilje, C., Desai, P., Amponsah, J. K., Umscheid, J., Parmar, N. G., Bhatt, N. S., Adupa, R., Pagad, S., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.03.019 · Cited by 53

Adamalysins in COVID-19 – Potential mechanisms behind exacerbating the disease

Dias, I. R. D. S. R., Cao, Z., & Kwok, H. F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112970 · Cited by 12

Giant cell myocarditis after first dose of BNT162b2 – a case report

Hirsch, V. G., Schallhorn, S., Zwadlo, C., Diekmann, J., Länger, F. P., Jonigk, D. D., Kempf, T., Schultheiß, H., & Bauersachs, J. K. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2590 · Cited by 13

Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?

Shahid, R., Tang, W. H. W., Klein, A. L., Kwon, D. H., & Amdani, S. M. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.06.011 · Cited by 12

Increased induction of de novo serum ANCA and ANCA-associated vasculitis after mass vaccination against SARS-CoV-2

Irure‐Ventura, J., Belmar, L., Fernández-Fresnedo, G., González-López, E., Castro‐Hernández, C., Rodrigo, E., Heras-Vicario, M., Ruiz, J. C., & López‐Hoyos, M. (2022) · iScience · doi:10.1016/j.isci.2022.104847 · Cited by 11

A systematic review of current status and challenges of vaccinating children against SARS-CoV-2

Zhang, M., Zhang, P., Liang, Y., Du, B., Li, L., Yu, Z., Wang, H., Wang, Q., Zhang, X., & Zhang, W. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.10.006 · Cited by 11

2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases

Branch of Cardiovascular Physicians of Chinese Medical Doctor Association (2023) · Cardiology Plus · doi:10.1097/cp9.0000000000000043 · Cited by 13

COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature

Jaiswal, V., Mukherjee, D., Ang, S. P., Kainth, T., Naz, S., Shrestha, A. B., Agrawal, V., Mitra, S., Chia, J. E., Jilma, B., et al. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101280 · Cited by 13

How to behave with paediatric myocarditis: imaging methods and clinical considerations

Sarro, R. D., Borrelli, N., Pelaia, G., Mendicino, A., Moscatelli, S., Leo, I., Vecchia, G. L., Mazza, G. A., Castaldo, L., Strangio, A., et al. (2025) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyaf025 · Cited by 11

Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022

Downes, K. J., Statler, V. A., Orscheln, R. C., Cousino, M. K., Green, M., Michaels, M. G., Muller, W. J., Sharma, T. S., Danziger‐Isakov, L. A., & Ardura, M. I. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab098 · Cited by 11

Association of clinical and epidemiological characteristics with COVID-19 BNT162b2 mRNA vaccine short-term adverse reactions in healthcare workers

Filippatos, F., Tatsi, E., Dellis, C., Dessypris, N., Syriopoulou, V., & Michos, A. G. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1985356 · Cited by 11

Myocarditis and pericarditis after COVID-19 messenger RNA vaccines

Goldman, R. D. (2022) · Canadian Family Physician · doi:10.46747/cfp.680117 · Cited by 10

A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination — a Case Report

Wang, S., Noumi, B., Malik, F., & Wang, S. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01357-0 · Cited by 11

Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology

Hamedi, K. R., Loftus, G., Traylor, L. B., Goodwin, R. L., & Arce, S. (2023) · Vaccines · doi:10.3390/vaccines11020362 · Cited by 13

Challenges and Recent Advancements in COVID-19 Vaccines

Wang, S.-C., Rai, C.-I., & Chen, Y. (2023) · Microorganisms · doi:10.3390/microorganisms11030787 · Cited by 11

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand

Mahasing, C., Doungngern, P., Jaipong, R., Nonmuti, P., Chimmanee, J., Wongsawat, J., Boonyasirinant, T., Wanlapakorn, C., Leelapatana, P., Yingchoncharoen, T., et al. (2023) · Vaccines · doi:10.3390/vaccines11040749 · Cited by 11

Infancia y COVID-19: Los efectos indirectos de la pandemia COVID-19 en el bienestar de niños, niñas y adolescentes

Díaz, F., & Fuentes, A. D. (2022) · Andes pediatrica · doi:10.32641/andespediatr.v93i1.4250 · Cited by 11

Ventricular tachycardia from myocarditis following COVID‐19 vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)

Lin, W., Yip, A. C. L., Evangelista, L. K. M., Wong, R. C.-C., Tan, H. C., Lim, T. W., & Singh, D. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14486 · Cited by 11

CMR findings after COVID-19 and after COVID-19-vaccination—same but different?

Doeblin, P., Jahnke, C., Schneider, M., Al-Tabatabaee, S., Götze, C., Weiß, K. J., Tanacli, R., Faragli, A., Witt, U., Stehning, C., et al. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02623-x · Cited by 12

Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature

Samim, M. M., Dhar, D., Arshad, F., Anudeep, D. D. S., PATEL, V. G., Neeharika, S. R., Dhamija, K., Ravindranath, C. M., Yadav, R., Raja, P., et al. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.12.015 · Cited by 11

Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity

Muñoz-Alía, M. Á., Nace, R. A., Balakrishnan, B., Zhang, L., Packiriswamy, N., Singh, G., Warang, P., Mena, I., Narjari, R., Vandergaast, R., et al. (2024) · mBio · doi:10.1128/mbio.02928-23 · Cited by 12

mRNA COVID vaccine and myocarditis in adolescents

Kwan, M. Y. W., Chua, G. T., Chow, C., Tsao, S. S. L., To, K. K., Yuen, K., Lau, Y., & Ip, P. (2021) · Hong Kong Medical Journal · doi:10.12809/hkmj215120 · Cited by 11

Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia

Deng, L., Eldik, A. V., O'Moore, M., Buttery, J. P., Cheung, A. W., Cox, N. R., Drake-Brockman, C., Dwyer, N., Effler, P. V., Gold, M., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01206-w · Cited by 11

Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study

Milito, C., Cinetto, F., Garzi, G., Palladino, A., Puca, M., Brambilla, E., Vitis, C. D., Costanzo, G. A. M. L., Scarpa, R., Punziano, A., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01402-6 · Cited by 10

Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program

Salmon, D. A., Chen, R. T., BLACK, S. B., & Sharfstein, J. M. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2305707 · Cited by 11

Clinical Manifestations and Outcomes of Older Patients with COVID-19: A Comprehensive Review

Lee, J. E., Kang, D. H., Kim, S.-Y., Kim, D. K., & Lee, S. (2024) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2023.0157 · Cited by 10

Case report: Myocarditis following COVID-19 protein subunit vaccination

Dong, Y.-M., Liu, X., Yang, C.-T., Qian, Q., Shi, W.-B., Li, Y., Zuo, M., Wang, S.-J., Bi, H., Ma, R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.970045 · Cited by 10

COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review

FERGIE, J. E., Moran, M. M., Cane, A. D., Pather, S., Türeci, Ö., & Srivastava, A. K. (2022) · Vaccines · doi:10.3390/vaccines10122039 · Cited by 10

Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in Singapore

Dorajoo, S. R., Tan, H. X., Teo, C. H. D., Neo, J. W., Koon, Y. L., Ng, J. J. A., Tham, M. Y., Foo, P. Q. B., Peck, L. F., Ang, P. S., et al. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100419 · Cited by 12

The Epidemiology of COVID-19 Vaccine-Induced Myocarditis

Costa, C., & Moniati, F. (2024) · Advances in Medicine · doi:10.1155/2024/4470326 · Cited by 10

COVID-19 vaccines for children in LMICs: another equity issue

Kampmann, B., & Okomo, U. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01748-7 · Cited by 11

Aseptic Meningitis Following the Second Dose of Comirnaty Vaccination in an Adolescent Patient

Lee, J. K. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003385 · Cited by 10

Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease

Shoji, K., Funaki, T., Yamada, M., Mikami, M., Miyake, K., Ueno, S., Tao, C., Myojin, S., Aiba, H., Matsui, T., et al. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.09.013 · Cited by 10

Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents

Puthanakit, T., Chantasrisawad, N., Yoohat, K., Nantanee, R., Sophonphan, J., Meepuksom, T., Sodsai, P., Phanthanawiboon, S., Jantarabenjakul, W., Hirankarn, N., et al. (2022) · Vaccines · doi:10.3390/vaccines10101646 · Cited by 10

COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey

Yoo, H., Kim, S. Y., Park, M. S., Jeong, S. H., Park, S.-W., Lee, H. L., Lee, H.-K., Yang, S., Jegal, Y., Yoo, J., et al. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e106 · Cited by 10

Сorrelation between age and the intensity of the post-vaccination humoral immune response in individuals passed COVID-19

Andreev, A. I., Andreev, I. V., Nechay, K. O., Esaulova, D. R., Baklakova, O. S., Vecherko, V. I., Shilovskiy, I. P., Кофиади, И. А., Гудима, Г. О., Martynov, A. I., et al. (2022) · Immunologiya · doi:10.33029/0206-4952-2022-43-5-583-592 · Cited by 18

Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study

Chen, C., Chen, C., Cao, L., Fang, J., & Xiao, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112022 · Cited by 10

Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?

Giovane, R., & Campbell, J. (2021) · Cureus · doi:10.7759/cureus.18977 · Cited by 9

A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2

Habedank, D., Lagast, A., Usme, M. M. N., & Atmowihardjo, I. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01946-4 · Cited by 9

COVID‐19 mRNA vaccine (Comirnaty)‐induced myocarditis

Wong, J. H., Sharma, S., Yao, J. V., Aggarwal, A., & Grigg, L. (2022) · The Medical Journal of Australia · doi:10.5694/mja2.51394 · Cited by 9

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective

Alami, A., Villeneuve, P. J., Farrell, P. J., Mattison, D. R., Farhat, N., Haddad, N., Wilson, K. R., Gravel, C. A., Crispo, J. A. G., Perez‐Lloret, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154971 · Cited by 10

Safety and durability of mRNA-1273–induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial

Figueroa, A. L., Ali, K., Berman, G., Zhou, H., Deng, W., Xu, W., Lussier, S. J., Girard, B., Dutko, F. J., Slobod, K., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102720 · Cited by 8

Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19

Long, F., Zhu, S., Wang, Z., Zhang, S., He, J., Ge, X., & Ning, J. (2023) · Future Virology · doi:10.2217/fvl-2022-0048 · Cited by 9

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada

Buchan, S. A., Alley, S., Seo, C. Y., Johnson, C., Kwong, J. C., Nasreen, S., Thampi, N., Lu, D., Harris, T. M., Calzavara, A. J., et al. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.6166 · Cited by 9

SARS-CoV-2 Related Myocarditis: What We Know So Far

Mistrulli, R., Ferrera, A., Muthukkattil, M. L., Volpe, M., Barbato, E., & Battistoni, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144700 · Cited by 10

Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective

Baylor, N. W., & Goodman, J. L. (2022) · Vaccines · doi:10.3390/vaccines10122136 · Cited by 8

SARS-CoV-2 vaccines and myocarditis

Sularz, A., Hua, A. X., & Ismail, T. F. (2023) · Clinical Medicine · doi:10.7861/clinmed.2023-0049 · Cited by 8

Safety of BNT162b2 mRNA COVID-19 vaccine in children with chronic kidney disease: a national population study from South Korea

Choe, Y. J., Ahn, Y.-H., Gwak, E. S., Jo, E., Kim, J., & Choe, S. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06195-3 · Cited by 8

A web-based genome-wide association study reveals the susceptibility loci of common adverse events following COVID-19 vaccination in the Japanese population

Nogawa, S., Kanamori, H., Tokuda, K., Kawafune, K., Chijiiwa, M., Saito, K., & Takahashi, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-47632-5 · Cited by 14

An overview of the COVID-19 pediatric vaccine program – The U.S. experience vaccinating children ages 6 months through 17 years

Chatham‐Stephens, K., Carter, R. J., Duggar, C., Woodworth, K. R., Carnes, C. A., Bhatt, A., Ottis, C., Voegeli, C., Stokley, S. K., & Vogt, T. M. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.02.019 · Cited by 8

Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever

Shechtman, L., Lahad, K., Livneh, A., Grossman, C., Druyan, A., Giat, E., Lidar, M., Freund, S., Manor, U., Pomerantz, A., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keac131 · Cited by 8

Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A Case Report and Literature Review

Wu, C.-T., Chin, S., & Chu, P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.856991 · Cited by 8

Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine

Mechleb, N., Khoueir, Z., & Assi, A. (2022) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2022.02.001 · Cited by 8

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

Leav, B. A., Straus, W. L., White, P., Leav, A., Gaines, T., Maggiacomo, G., Kim, D., Smith, E. R., Gurwith, M., & Chen, R. T. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.005 · Cited by 9

Case report: Five patients with myocarditis after mRNA COVID-19 vaccination

Murase, H., Zhu, Y., Sakaida, K., Mizuno, H., Mori, H., Iwayama, H., Suzuki, N., Nagai, N., & Okumura, A. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.977476 · Cited by 8

Autoimmune Rheumatic Disease Flares with Myocarditis Following COVID-19 mRNA Vaccination: A Case-Based Review

Lai, Y. W., Chua, C. G., Lim, X. R., Francis, P. J., Xu, C., & Howe, H. S. (2022) · Vaccines · doi:10.3390/vaccines10101772 · Cited by 8

Rolle, Arbeitsweise und Empfehlungen der Ständigen Impfkommission (STIKO) im Kontext der COVID-19-Pandemie

Vygen-Bonnet, S., Schlaberg, J., & Koch, J. (2022) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-022-03610-2 · Cited by 8

Current evidence of COVID-19 vaccination-related cardiovascular events

Khiali, S., Rezagholizadeh, A., Behzad, H., Baghi, H. B., & Entezari‐Maleki, T. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2161249 · Cited by 8

Imaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination

Tijmes, F. S., Marschner, C., de Matos, J. F. R. G., Fresno, C. M. U., Chacoff, J. M. G., Thavendiranathan, P., Fuss, C., & Hanneman, K. A. (2023) · Radiographics · doi:10.1148/rg.230044 · Cited by 8

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccinesPreprint

de Bruyn, G., Wang, J., Purvis, A., Ruiz, M. S., Adhikarla, H., Alvi, S., Bonaparte, M. I., Brune, D., Bueso, A., Canter, R. M., et al. (2022) · medRxiv · doi:10.1101/2022.12.02.22282931 · Cited by 8

Myocarditis incidence and hospital mortality from 2007 to 2022: insights from a nationwide registry

Rottmann, F. A., Glück, C., Kaier, K., Bemtgen, X., Supady, A., Mühlen, C. V. Z., Westermann, D., Wengenmayer, T., & Staudacher, D. L. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02494-3 · Cited by 9

Harnessing the Potential of mRNA Vaccines Against Infectious Diseases

Rezk, N., & McClean, S. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70212 · Cited by 10

Rationalizing recommendations for influenza and COVID-19 vaccines

Breznik, J. A., Miller, M. S., & Bowdish, D. M. E. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127775 · Cited by 9

Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccine

Wu, B., Mittal, N., ADLER, E. D., & Hong, K. N. (2022) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2021.12.009 · Cited by 7

A Case Report for Acute Myopericarditis After NVX-CoV2373 (Novavax®) COVID-19 Vaccination

Kim, H. Y., Cho, J. Y., Yoon, H. J., Choi, Y. D., Ahn, Y., Jeong, M. H., Cho, J. G., & Kim, K. H. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e265 · Cited by 7

Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents

Lee, J. S., Choi, H., Shin, S. H., Hwang, M.-J., Na, S., Kim, J. H., Park, S., Yoon, Y., Kang, H. M., Ahn, B., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.04.032 · Cited by 7

Imaging Findings of COVID-19–Related Cardiovascular Complications

Nakou, E. S., Gárate, E. D., Liang, K., Williams, M. G. L., Pennell, D. J., & Bucciarelli‐Ducci, C. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2021.10.008 · Cited by 7

COVID Vaccination in Athletes & Updated Interim Guidance on the Preparticipation Physical Examination during the SARS-CoV-2 Pandemic

Narducci, D. M., Diamond, A. B., Bernhardt, D. T., & Roberts, W. O. (2021) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000912 · Cited by 7

The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis

Klamer, T. A., Linschoten, M., & Asselbergs, F. W. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01677-9 · Cited by 10

Case Series of Potential Cardiac Inflammation Associated With Various SARS-CoV-2 Vaccinations Assessed by Cardiac MRI

Jahnke, C., Doeblin, P., Tanacli, R., Witt, U., Schneider, M., Stehning, C., Pieske, B. M., & Kelle, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.829392 · Cited by 7

Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next

Corey, K. B., Koo, G., & Phillips, E. J. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.04.035 · Cited by 9

Bilateral Vocal Fold Paralysis After COVID-19 mRNA Vaccination: A Case Report

Son, S. A., Kim, Y. J., Lim, S. Y., & Kim, H. B. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e201 · Cited by 7

Fulminant myocarditis after the first dose of mRNA-1273 vaccination in a patient with previous COVID-19: a case report

Horiuchi, K., Kosugi, S., Abe, H., & Ueda, Y. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac290 · Cited by 7

Case Report: Importance of MRI Examination in the Diagnosis and Evaluation of COVID-19 mRNA Vaccination Induced Myocarditis: Our Experience and Literature Review

Watanabe, K., Ashikaga, T., Maejima, Y., Tao, S., Terui, M. M., Kishigami, T., Kaneko, M., Nakajima, R., Okata, S., Lee, T., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.844626 · Cited by 7

Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years

Kim, S., Heo, Y., Seo, S.-Y., Lim, D. S., Cho, E., & Lee, Y.-K. (2022) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2022.0233 · Cited by 7

An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline

Tadfor, Y., Nguyen-Hua, N., Bennett, H., Bos, A. J., & Smolinske, S. C. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2147272 · Cited by 7

Clinical course and follow-up of pediatric patients with COVID-19 vaccine-associated myocarditis compared to non–vaccine-associated myocarditis within the prospective multicenter registry—“MYKKE”

Rolfs, N., Huber, C., Schwarzkopf, E., Mentzer, D., Keller‐Stanislawski, B., Opgen‐Rhein, B., Frede, W., Rentzsch, A., Hecht, T., Boehne, M., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.11.006 · Cited by 9

How Can We Best Use COVID-19 Vaccines in Adolescents? An International Perspective

Zhong, Y., Lee, L. Y., Tambyah, P. A., Liew, W. K., & Lee, B. W. (2021) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2021.08.014 · Cited by 7

A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination

Kim, S. H., Lee, S. Y., Kim, G. Y., Oh, J. S., Kim, J., Chun, K. J., Ju, M. H., Lee, C.-H., Song, Y., & Na, J. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e104 · Cited by 7

Should COVID-19 vaccines be mandated in schools? - an international caregiver perspective

Baumer-Mouradian, S. H., Hart, R., Bone, J. N., Seiler, M., Olson, P., Keitel, K., Manzano, S., Gualco, G., Krupik, D., Schroter, S., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.07.038 · Cited by 7

Myocarditis After COVID‐19 Vaccination in Pediatrics: A Proposed Pathway for Triage and Treatment

Sandeep, N., Fairchok, M. P., & Hasbani, K. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026097 · Cited by 7

COVID-19 and Myocarditis: Trends, Clinical Characteristics, and Future Directions

Abumayyaleh, M., Schupp, T., Behnes, M., El‐Battrawy, I., Hamdani, N., & Akın, İ. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134560 · Cited by 8

Rural–Urban Disparities in COVID-19 Vaccine Uptake and Associated Mortality and Cardiovascular Disease Outcomes in the United States

Smith, B., Farakh, F., Hanif, A., Tunio, J. H., & Tunio, S. N. J. (2025) · Vaccines · doi:10.3390/vaccines13080861 · Cited by 7

Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models

Zirkenbach, V. A., Ignatz, R. M., Öttl, R., Cehreli, Z., Stroikova, V., Kaya, M., Lehmann, L., Preusch, M. R., Frey, N., & Kaya, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055011 · Cited by 6

Adverse Events Following Vaccines: From Detection to Research Translation

Fernandez, E., Jaggers, J. L., Norton, A. E., Stone, C. A., & Phillips, E. J. (2024) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-071723-102841 · Cited by 6

COVID-19 Vaccine Hesitancy and Refusal:

Rellosa, N. (2022) · Delaware Journal of Public Health · doi:10.32481/djph.2022.03.011 · Cited by 6

Immunological response and temporal associations in myocarditis after COVID-19 vaccination using cardiac magnetic resonance imaging: An amplified T-cell response at the heart of it?

Vágó, H., Szabó, L. E., Szabo, Z., Ulakcsai, Z., Szögi, E., Budai, G., Tóth, A., Juhász, V., Dohy, Z., Hoffer, K., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.961031 · Cited by 6

Answers to common questions about COVID‐19 vaccines in children with cancer

Caniza, M. A., Homsi, M. R., Bate, J. M., Adrizain, R., Ahmed, T., Alexander, S. W., Bhattacharyya, A., Copado-Gutiérrez, J. L., Gutiérrez-Tobar, I. F., Lim, Y. Y., et al. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29985 · Cited by 6

Vaccines: An overview

Lopez, S. M. C., Sato, A. I., & Chatterjee, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85730-7.00015-1 · Cited by 7

Consenso de expertos sobre el diagnóstico y el tratamiento de la miocarditis asociada con infección o vacunación contra el SARS-CoV-2

Barreiro‐Pérez, M., Pueyo, P. P., Raposeiras‐Roubín, S., Corominas, D. M., Uribarri, A., Bachiller, R. E., Rozado, J., Álvarez, L. G.-C., Serratosa, L., Domínguez, F., et al. (2023) · Revista Española de Cardiología · doi:10.1016/j.recesp.2023.01.010 · Cited by 6

Cardiac Manifestations of Viral Infections, Including COVID-19: A Review

Weisleder, H., Jacobson, E., Frishman, W. H., & Dhand, A. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000481 · Cited by 6

Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management

Barreiro‐Pérez, M., Pueyo, P. P., Raposeiras‐Roubín, S., Corominas, D. M., Uribarri, A., Bachiller, R. E., Rozado, J., Álvarez, L. G.-C., Serratosa, L., Domínguez, F., et al. (2023) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2023.01.011 · Cited by 5

COVID-19: Findings in nuclear medicine from head to toe

Vaz, N., Franquet, E., Heidari, P., Chow, D. Z., Jacene, H. A., & Ng, T. S. C. (2023) · Clinical Imaging · doi:10.1016/j.clinimag.2023.04.003 · Cited by 6

Fulminant myocarditis following SARS-CoV-2 mRNA vaccination rescued with venoarterial ECMO: A report of two cases

Vila‐Olives, R., Uribarri, A., Martínez-Martínez, M., Argudo, E., Bonilla, C., Chiscano‐Camón, L., Herrador, L., Gabaldón, A., Buera, I., Vidal, M., et al. (2023) · Perfusion · doi:10.1177/02676591231170480 · Cited by 6

Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses

Katoto, P. D., Kakubu, M. A., Tamuzi, J. L., Brand, A., Ayuk, A. C., Byamungu, L. N., Wiysonge, C. S., & Gray, G. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2204154 · Cited by 6

Multimodality Cardiac Imaging in COVID

Holby, S. N., Richardson, T. L., Laws, J. L., McLaren, T. A., Soslow, J. H., Baker, M., Dendy, J. M., Clark, D. E., & Hughes, S. G. (2023) · Circulation Research · doi:10.1161/circresaha.122.321882 · Cited by 6

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023

Romanson, B., Moro, P. L., Su, J. R., Marquez, P. L., Nair, N., Day, B. F., DeSantis, A., & Shimabukuro, T. T. (2023) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7231a4 · Cited by 6

Cryptic late‐onset myocarditis after coronavirus vaccination

Forsdyke, D. R. (2024) · The FASEB Journal · doi:10.1096/fj.202302692rr · Cited by 6

Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines

Son, C.-S., Jin, S. H., & Kang, W. (2022) · Vaccines · doi:10.3390/vaccines10020284 · Cited by 6

COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device

Khan, M. Z., Janus, S. E., Franklin, S. M., Figueredo, V. M., Baqi, A., & Alvarez, R. (2022) · Cureus · doi:10.7759/cureus.24477 · Cited by 6

The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis

Klamer, T. A., Linschoten, M., & Asselbergs, F. W. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01677-9 · Cited by 10

Myocarditis and pericarditis after COVID-19 messenger RNA vaccines

Goldman, R. D. (2022) · Canadian Family Physician · doi:10.46747/cfp.680117 · Cited by 10

mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation

Fenton, C., & Lee, A. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00956-0 · Cited by 5

Assessment of Pediatric Myocarditis and Pericarditis Complication after mRNA-based COVID-19 Vaccination

Parikh, T. K. (2022) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/cimms/v5/3459c · Cited by 5

Pediatric Myocarditis and Pericarditis Complication after mRNA-based COVID-19 Vaccination

Parikh, T. K. (2022) · Asian Journal of Pediatric Research · doi:10.9734/ajpr/2022/v9i230261 · Cited by 1